Simon C M Kwok Selected Research

pectenotoxin 1

2/2014	Characterization of a variant of ERGIC2 transcript.
9/2006	PTX1(ERGIC2)-VP22 fusion protein upregulates interferon-beta in prostate cancer cell line PC-3.
7/2003	Effects of PTX1 expression on growth and tumorigenicity of the prostate cancer cell line PC-3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon C M Kwok Research Topics

Disease

3	Carcinoma (Carcinomatosis) 02/2014 - 07/2003
3	Neoplasms (Cancer) 01/2013 - 01/2011
2	Prostatic Neoplasms (Prostate Cancer) 09/2006 - 07/2003
1	Iron Deficiencies 01/2013
1	Lead Poisoning (Poisoning, Lead) 01/2013
1	Adenocarcinoma 02/2012
1	Bone Fractures (Bone Fracture) 01/2011

Drug/Important Bio-Agent (IBA)

3	pectenotoxin 1IBA 02/2014 - 07/2003
1	Heme Oxygenase-1IBA 01/2013
1	Bovine Serum AlbuminIBA 01/2013
1	SuspensionsIBA 01/2013
1	zinc protoporphyrinIBA 01/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2012
1	Atorvastatin (Lipitor)FDA Link 02/2012
1	Bone Cements (Bone Glue)IBA 01/2011
1	Proteins (Proteins, Gene)FDA Link 09/2006
1	Interferon-betaIBA 09/2006
1	Nuclear Proteins (Protein, Nuclear)IBA 07/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2011